Literature DB >> 32594362

Difference in Metabolomic Response to Exercise between Patients with and without Hypertrophic Cardiomyopathy.

Yuichi J Shimada1,2, Jaya Batra3, Stephanie M Kochav3, Parth Patel3, Jeeyoun Jung4, Mathew S Maurer3, Kohei Hasegawa5, Muredach P Reilly3, Michael A Fifer6.   

Abstract

It is unclear how hypertrophic cardiomyopathy (HCM) affects cardiac metabolic pathways at rest and with exercise. This case-control study compared 15 cases with HCM to 2 control groups without HCM. Metabolomic profiling of 210 metabolites was carried out at rest and at peak exercise. The 50 most discriminant metabolites differentially regulated during exercise were selected using partial least squares discriminant analysis. Pathway enrichment analysis was also performed. At rest, no significant difference was observed in metabolomic profiling of HCM cases as compared to controls. By contrast, there were significant differences in metabolomic profiling in response to exercise (p < 0.05) in the following metabolic pathways: the aminoacyl-tRNA biosynthesis pathway; the nitrogen metabolism pathway; the glycine, serine, and threonine metabolism pathway; and the arginine and proline metabolism pathway. The present study demonstrates differential regulation of several metabolic pathways in patients with HCM in the setting of exercise stress.

Entities:  

Keywords:  Exercise; Hypertrophic cardiomyopathy; Metabolomics

Mesh:

Substances:

Year:  2020        PMID: 32594362     DOI: 10.1007/s12265-020-10051-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  2 in total

1.  Myocardial metabolic changes in hypertrophic cardiomyopathy.

Authors:  E Tadamura; N Tamaki; A Matsumori; Y Magata; Y Yonekura; R Nohara; S Sasayama; M Yoshibayashi; T Kamiya; J Konishi
Journal:  J Nucl Med       Date:  1996-04       Impact factor: 10.057

2.  Multivariate Analysis in Metabolomics.

Authors:  Bradley Worley; Robert Powers
Journal:  Curr Metabolomics       Date:  2013
  2 in total
  6 in total

1.  Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension.

Authors:  Emilia M Swietlik; Pavandeep Ghataorhe; Kasia I Zalewska; John Wharton; Luke S Howard; Dolores Taboada; John E Cannon; Nicholas W Morrell; Martin R Wilkins; Mark Toshner; Joanna Pepke-Zaba; Christopher J Rhodes
Journal:  Eur Respir J       Date:  2021-04-01       Impact factor: 16.671

2.  Metabolomics in Exercise and Sports: A Systematic Review.

Authors:  Kayvan Khoramipour; Øyvind Sandbakk; Ammar Hassanzadeh Keshteli; Abbas Ali Gaeini; David S Wishart; Karim Chamari
Journal:  Sports Med       Date:  2021-10-30       Impact factor: 11.136

3.  Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population.

Authors:  Bradley S Lander; Yanling Zhao; Kohei Hasegawa; Mathew S Maurer; Albree Tower-Rader; Michael A Fifer; Muredach P Reilly; Yuichi J Shimada
Journal:  Front Cardiovasc Med       Date:  2022-06-17

4.  Antibacterial Activity and Mechanism of Linalool against Shewanella putrefaciens.

Authors:  Fengyu Guo; Qiong Liang; Ming Zhang; Wenxue Chen; Haiming Chen; Yonghuan Yun; Qiuping Zhong; Weijun Chen
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

5.  Plasma metabolomic profiling of hypertrophic cardiomyopathy patients before and after surgical myectomy suggests postoperative improvement in metabolic function.

Authors:  Nicole L Wolter; Madison J LeClair; Michael T Chin
Journal:  BMC Cardiovasc Disord       Date:  2021-12-28       Impact factor: 2.298

6.  Metabolic Signature of Arrhythmogenic Cardiomyopathy.

Authors:  Chiara Volani; Johannes Rainer; Vinicius Veri Hernandes; Viviana Meraviglia; Peter Paul Pramstaller; Sigurður Vidir Smárason; Giulio Pompilio; Michela Casella; Elena Sommariva; Giuseppe Paglia; Alessandra Rossini
Journal:  Metabolites       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.